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Abstract 
This study compares sentinel lymph-node biopsy carried out at the time of removal of the primary breast tumour, under general 
anaesthetic, with sentinel lymph-node biopsy carried out under local anaesthetic prior to the main operation. It compares the total cost of 
the two treatment approaches, in terms of average income and of their impact on the subsequent programming of operations and hence 
on waiting lists and income.
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Introduction
Sentinel lymph-node biopsy (SLNB) is a surgical technique 
used in the staging of breast cancer [1]. 
Various randomized clinical studies have compared the efficacy 
of sentinel lymph-node biopsy versus conventional axillary 
lymph-node dissection; at the moment the only published 
results are of a randomized clinical trial carried out at this 
institute, which confirm the accuracy of SLNB in assessing 
axillary lymph-node metastases, without increasing the risk of 
local relapse [2,3]. 
Furthermore, the thoroughness of the histological examination 
used to analyse the sentinel lymph-node (60 histological 
sections compared to three sections for the standard), indicated 
  that this procedure was more reliable than the conventional 
histological examination, identifying axillary metastases in more 
cases (from 25–36% in T1 tumours) [4,5]. 
In view of these results, the SLNB procedure can be considered 
to all effects the standard clinical procedure (Evidence Based 
Medicine: level 1). 
The large scale use of this technique will reduce the overall 
costs of treatment, in terms of shorter periods of hospitalization 
and a reduction in the complications associated with complete 
axillary lymph-node dissection. 
In fact, the need for post-operative assistance, i.e. medication 
and physiotherapy, are notably reduced after this procedure 




However, if the histological examination of the lymph node is 
carried out intra-operatively, about 20–60 minutes are required 
to obtain the extemporal result, prolonging the occupancy of the 
operating theatre and so hindering the programming of 
successive operations. Hence, in our institute, from September 
2000, we have started to perform SLNB under local anaesthetic 
in day surgery, in patients with clear diagnosis of mammary 
carcinoma. 
If the histological examination is definitive, and not extemporal, 
the SLN is evaluated before any successive operation to 
remove the primary neoplasia, which will be carried out under 
routine hospital recovery. 
In 2002, we published the first clinical results from 115 patients, 
which confirmed the feasibility and safety of this procedure [9]. 
 
 
The aim of this study is to compare SLNB carried out at the time 
of the removal of the primary tumour under general anaesthetic 
(Figure 1) with SLNB carried out under local anaesthetic prior to 
the main operation under general anaesthetic (Figure 2). 
The aim is to compare the total cost of the two treatment 
approaches, in terms of average income and of their impact on 
the subsequent programming of operations and hence on 
waiting lists and income. 
 
Materials and methods
From September 2000 to December 2005, within the European 
Institute of Oncology of Milan, 1018 patients with mammary





















carcinoma at stage cT1–cT2N0 (age range 27–83) were given a 
SLNB under local anaesthetic; all the patients, following 
analysis of the SLN, underwent treatment for the primitive 
neoplasia. 
All the patients eligible for SLNB were treated in this manner, 
with the exception of obese patients or those with tumour 
progression into the axillary region. The median follow-up period 
was 19.7 months (range 1.0–76.0). 
As this is a diagnostic procedure aimed at staging, the SLNB is 
carried out prior to the main surgical intervention to the breast 
and is carried out under local anaesthetic in day hospital. The 
possibility of programming the main surgical event after the 
result of the SLNB allows for a drastic reduction in the recovery 
period and hence in both the direct and indirect costs 
associated with the procedure. 
 
Surgical techniques
Radio-guided surgery is easy to use and does not require 
specific surgical training for surgeons already expert in 
oncological breast surgery. 
The technique of SLNB under local anaesthetic does not differ 
substantially from that carried out under general anaesthetic. 
The surgical incision is just a few centimetres long and follows a 
natural axillary skin fold, within the hypothetical ‘italics’ incision 
line used for axillary dissections. It is always important to 
consider successive surgical treatments to the breast, and so if 
the neoplasia is located in the super-external quadrant, a 
quadrantectomy with an eventual axillary dissection will be 
carried out. In this case, the ideal incision will be along the 
lateral edge of the large pectoral muscle. 
 
Results
The definitive histological examination of the tumours of those 
patients who underwent an SLNB under local anaesthetic 
demonstrated that the SLN was negative for metastases in 595 
cases (58.4%) and had ‘isolated tumour cells’ (ITC) pN0 (+ic) in 
48 cases (4.7%). The remaining 18% had micro-metastases in 
the SLN (Table 3); of these approximately half took part in a 
randomized study in which no surgical treatment to the axilla 
was compared with axillary dissection. Hence, in total, 72.1% of 
the patients did not undergo successive axillary dissection. 
The definitive histological examination indicated macro-
metastases of the SLN in only 18.9% of the cases, and these 
patients had axillary dissection during the subsequent 
operation. The number of axillary relapses (0.2%) (Table 4) was 
less than expected (8%). The economic outcome is evaluated 
by analysing in detail the direct costs of the procedure 
(materials and medicines), the indirect costs, the cost of 
personnel, of the recovery and the cost of the pathology 
laboratory. The SLNB carried out under local anaesthetic costs 
€509; this value must be considered as part of the complete 




















Table 1: SLNB during primary surgery 
 
 
procedure, carried out as a standard recovery, as the income 
will be added to that of the standard recovery budget. 
If the SLNB is performed together with the quadrantectomy 
under general anaesthetic, (Table 1, Treatment 1A), it has a 
total cost of €2268, offset by an income of €2925, leaving a 
margin of €657. 
If instead the SLNB is performed under local anaesthetic with a 
successive quadrantectomy in standard recovery (Table 2, 
Treatment 2A), the total cost is €1796 offset by an income of 
€2925, leaving a margin of €1129. 
Treatment 1B (Table 1), i.e. quadrantectomy plus SLNB and 
axillary dissection has a total cost of €3346 offset by an income 
of €4596, leaving a margin of €1250. 
If instead the SLNB is performed under local anaesthetic with a 
successive quadrantectomy and axillary dissection in standard 
recovery (Treatment 2B, Table 2), the total cost is €2866 offset 
by an income of €4596, leaving a margin of €1730. 
From an economic point of view, Treatment 1, SLNB under 
general anaesthetic, had higher indirect costs with respect to 
Treatment 2, i.e. SLNB under local anaesthetic, and some of 
the direct costs were also higher: operating room personnel and 
recovery. As the income is the same for the two procedures, the 
margin is 42% higher if the SLN is negative, and 28% higher if 
the SLN is positive. 
 
Conclusions
The use of SLNB is well established, and the procedural and 
economic differences between the two treatments are made 
evident here. From an economic point of view, carrying out a 
definitive histological examination of the SLN as opposed to an 
extemporal one allows a reduction in the time of the operation, 
meaning that more surgical interventions can be programmed 
successively, so reducing waiting lists and pathology laboratory 
expenses. By carrying out the SLNB under local anaesthetic, 



















Table 2: SLNB in day hospital (local anaesthetic) 
 
 
Table 3: Histology of the SLN in 1018 cases 
 
 
Table 4  



















more precise programming of the definitive surgical treatment 
can be made in at least 60% of the cases so reducing the 
waiting list. 
From this analysis, it also emerges that in cases that undergo 
axillary dissection due to SLN positivity in approximately 50% of 
cases the SLN is the only node affected. In these cases, axillary
dissection of the histologically negative nodes does not 
influence the weight of the DRG as the initial positivity of the 
SLN is not taken into consideration. For the same procedure 
carried out under general anaesthetic, the positivity of a single 
SLN affects positively the weight of the DRG. This is the only 
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